Because growth hormone is released in unpredictable pulses, a resting blood sample cannot reliably distinguish a healthy pituitary from a deficient one. A stimulation test solves this by deliberately provoking a GH response and measuring how the pituitary reacts, rather than relying on a passive snapshot.
This test is typically ordered only after initial screening — usually an IGF-1 blood test combined with relevant clinical signs — suggests deficiency is plausible, since it is a more involved procedure than a routine blood draw.
Stimulation testing is conducted in a clinical setting under medical supervision, typically involving a period of monitoring with blood samples drawn at intervals to track how GH levels respond over the course of the test.
The exact clinical protocol, substances used, and monitoring schedule are determined entirely by the treating physician based on established clinical guidelines and the patient's specific situation — this is medical procedure territory, not something described in general terms here.
A blunted or absent GH response to the stimulus supports a diagnosis of growth hormone deficiency, while a normal response generally rules it out, though results are always interpreted by the treating physician alongside the full clinical picture rather than in isolation.
In adults, this testing is usually pursued only after a documented cause is identified, such as pituitary damage, surgery, radiation, or a tumor, since adult-onset deficiency is typically acquired rather than discovered incidentally.
This article describes the general purpose and clinical context of stimulation testing as reported in endocrinology literature. It does not describe specific test protocols, substances, or procedures in detail, since those are determined by treating physicians on a case-by-case basis.
This is not medical advice, and REVIVE LAB UAE does not perform, interpret, or advise on any diagnostic testing.